CRP and Alzheimer disease: Survival analysis conducted separately among subjects with CRP levels less than 8 mg/L and 8 mg/L or greater revealed that conversion from MCI to AD was impacted only among those with the SPI1 rs1057233-AA or CD33 rs3865444-CC genotypes (Fig. 4a, b).